| Literature DB >> 35425576 |
Karim Chkirate1, Khalid Karrouchi2, Hind Chakchak3, Joel T Mague4, Smaail Radi5, N N Adarsh6, Weiyang Li7, Ahmed Talbaoui8, El Mokhtar Essassi1, Yann Garcia7.
Abstract
Two mononuclear coordination complexes of N-(2-aminophenyl)-2-(5-methyl-1H-pyrazol-3-yl)acetamide (L1), namely [Cd(L1)2Cl2] (C1) and [Cu(L1)2(C2H5OH)2](NO3)2 (C2) and one mononuclear complex [Fe(L2)2(H2O)2](NO3)2·2H2O (C3), obtained after in situ oxidation of L1, have been synthesized and characterized spectroscopically. As revealed by single-crystal X-ray diffraction, each coordination sphere made of two heterocycles is completed either by two chloride anions (in C1), two ethanol molecules (in C2) or two water molecules (in C3). The crystal packing analysis of C1, C2 and C3, revealed 1D and 2D supramolecular architectures, respectively, via various hydrogen bonding interactions, which are discussed in detail. Furthermore, evaluation in vitro of the ligands and their metal complexes for their antibacterial activity against Escherichia coli (ATCC 4157), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (ATCC 25923) and Streptococcus fasciens (ATCC 29212) strains of bacteria, revealed outstanding results compared to chloramphenicol, a well-known antibiotic, with a normalized minimum inhibitory concentration as low as 5 μg mL-1. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 35425576 PMCID: PMC8981392 DOI: 10.1039/d1ra09027e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 3.361
Fig. 1Structures of N-(2-aminophenyl)-2-(5-methyl-1H-pyrazol-3-yl)acetamide (L1) and 3-(5-methyl-1H-pyrazol-3-yl)quinoxalin-2(1H)-one (L2).
Refinement parameters and crystal data for C1, C2 and C3
| CCDC number | C1 | C2 | C3 |
|---|---|---|---|
|
|
|
| |
|
| |||
| Chemical formula | C24H28CdCl2N8O2 | C28H40CuN8O4·2(NO3) | C24H24FeN8O4·2(NO3)·2(H2O) |
|
| 643.84 | 740.24 | 704.41 |
| Crystal system, space group | Monoclinic, | Triclinic, | Triclinic, |
|
| 150 | 240 | 150 |
|
| 13.7075(8), 21.2787(13), 9.1536(6) | 9.0258(5), 10.0091(6), 11.2402(6) | 8.392(3), 11.420(4), 15.823(6) |
|
|
| 74.769(1), 66.668(1), 80.782(1) | 78.679(4), 86.124(4), 80.487(4) |
|
| 2659.2(3) | 897.84(9) | 1465.5(9) |
|
| 4 | 1 | 2 |
| Radiation type | Mo Kα | Mo Kα | Mo Kα |
|
| 1.06 | 0.67 | 0.60 |
| Crystal size (mm) | 0.35 × 0.13 × 0.12 | 0.27 × 0.12 × 0.11 | 0.28 × 0.25 × 0.04 |
|
| |||
| Diffractometer | Bruker Smart APEX CCD | ||
| Absorption correction | Multi-scan SADABS | ||
|
| 0.75, 0.88 | 0.82, 0.93 | 0.73, 0.98 |
| No. of measured, independent and observed [ | 25873, 7227, 6853 | 16816, 4438, 3338 | 12137, 6014, 3364 |
|
| 0.029 | 0.031 | 0.042 |
| (sin | 0.698 | 0.668 | 0.629 |
|
| |||
|
| 0.023, 0.053, 1.03 | 0.045, 0.129, 1.03 | 0.069, 0.215, 1.00 |
| No. of reflections | 7227 | 4438 | 6014 |
| No. of parameters | 337 | 241 | 427 |
| No. of restraints | 2 | 29 | |
| H-atom treatment | H-atom parameters constrained | H-atom parameters constrained | H-atom parameters constrained |
| Δ | 1.09, −0.24 | 0.58, −0.22 | 1.35, −0.45 |
| Absolute structure | Refined as an inversion twin | ||
| Absolute structure parameter | 0.267(16) | ||
Scheme 1Synthetic route for preparation of L1.
Hydrogen-bond geometry (Å, °) of C1, C2 and C3a
| D–H⋯A | D–H | H⋯A | D⋯A | D–H⋯A | Symmetry codes |
|---|---|---|---|---|---|
| C1 | |||||
| N1–H1A⋯Cl2 | 0.91 | 2.57 | 3.469(3) | 169 |
|
| N1–H1B⋯Cl1 | 0.91 | 2.52 | 3.259(3) | 139 |
|
| N2–H2A⋯Cl2 | 0.91 | 2.61 | 3.280(3) | 131 |
|
| N4–H4A⋯N5 | 0.91 | 2.06 | 2.954(4) | 168 |
|
| N5–H5A⋯Cl2 | 0.91 | 2.59 | 3.318(3) | 137 |
|
| N5–H5B⋯Cl1 | 0.91 | 2.59 | 3.473(3) | 165 |
|
| N6–H6A⋯O2 | 0.91 | 2.29 | 3.186(4) | 170 |
|
| N8–H8A⋯N1 | 0.91 | 2.04 | 2.937(4) | 171 |
|
| C10–H10⋯Cl1 | 0.95 | 2.74 | 3.617(3) | 154 |
|
| C4–H4⋯Cg2 | 0.95 | 2.89 | 3.587(4) | 131 |
|
| C22–H22⋯Cg5 | 0.95 | 2.82 | 3.6939(3) | 144 |
|
| C2 | |||||
| N1–H1A⋯O2 | 0.91 | 2.17 | 3.062(3) | 166 | − |
| N1–H1B⋯O3 | 0.91 | 2.12 | 3.028(6) | 173 |
|
| N2–H2A⋯O2 | 0.91 | 1.96 | 2.857(2) | 167 |
|
| N4–H4A⋯N1 | 0.91 | 2.05 | 2.958(2) | 173 | − |
| C5–H5⋯O4 | 0.94 | 2.54 | 3.431(8) | 158 | − |
| C10–H10⋯O4 | 0.94 | 2.39 | 3.329(4) | 173 | − |
| C12–H12B⋯O3 | 0.97 | 2.46 | 3.388(6) | 161 | − |
| O5–H5A⋯O2 | 0.87 | 2.17 | 2.898(2) | 141 |
|
| O5–H5A⋯O4 | 0.87 | 2.45 | 3.262(5) | 156 |
|
| C3 | |||||
| O3–H3A⋯N1 | 0.87 | 2.00 | 2.855(4) | 168 | − |
| O3–H3B⋯O10 | 0.87 | 1.89 | 2.708(11) | 157 |
|
| O3–H3B⋯N10 | 0.87 | 2.52 | 3.381(17) | 173 |
|
| O4–H4A⋯O12 | 0.87 | 1.80 | 2.638(5) | 162 |
|
| O4–H4B⋯N5 | 0.87 | 1.99 | 2.856(4) | 174 | − |
| N2–H2A⋯O7 | 0.91 | 1.91 | 2.805(4) | 166 |
|
| N3–H3C⋯O11 | 0.91 | 2.02 | 2.917(4) | 169 |
|
| N6–H6A⋯O11 | 0.91 | 1.94 | 2.845(4) | 173 |
|
| N7–H7C⋯O7 | 0.91 | 1.98 | 2.885(4) | 176 |
|
| C14–H14⋯O5 | 0.95 | 2.54 | 3.400(5) | 175 |
|
| C24–H24A⋯O9 | 0.98 | 2.49 | 3.47(3) | 173 | − |
| O11–H11A⋯O6 | 0.87 | 2.05 | 2.853(4) | 153 |
|
| O11–H11B⋯O9 | 0.87 | 1.76 | 2.61(2) | 167 |
|
| O12–H12D⋯O5 | 0.87 | 1.96 | 2.814(6) | 168 |
|
| O12–H12D⋯N9 | 0.87 | 2.57 | 3.359(6) | 151 |
|
| O12–H12E⋯O9 | 0.87 | 2.01 | 2.87(14) | 170 |
|
C1: Cg2 and Cg5 are, respectively, the centroids of the N7/N8/C32/C22/C21 and C1⋯C6 rings.
Scheme 2Plausible reaction mechanism for the formation of L2.
Fig. 2Asymmetric unit of C1 (a), C2 (b) and C3 (c). Color codes: C – orange, N – blue, H – white, Cd – Magenta, Cu – dark orange, Fe – green, O – red, Cl – green.
Fig. 3Crystal structure illustration of C1, (a) 1D hydrogen bonded chains (black dotted lines represent the N–H⋯Cl interactions), (b) parallel packing of 1D chains (view along crystallographic axis ‘b’), (c) TOPOS view of the parallel packing of 1D chains.
Fig. 4Crystal structure illustration of C2, (a) the N–H⋯O and O–H⋯O hydrogen bonding in C2 displaying the R21(9) ring, (b) various hydrogen bonding and the view of R21(11), R21(9) and R21(8) rings, (c) TOPOS view of 2D hydrogen bonded sheet, (d) the stacking of 2D layers along crystallographic axis ‘a’ (adjacent 2D layers are shown in orange, green and magenta).
Fig. 5Crystal structure illustration of C3, (a) 1D chain self-assembly of C3 through R44(12) rings via various hydrogen bonding, (b) 2D hydrogen bonded assembly, (c) TOPOS view of 2D hydrogen bonded network, (d) 3D hydrogen bonded network, (e) TOPOS view of 3D [32·6-c]-connected net.
Fig. 6The dnorm Hirshfeld surfaces of C1 (a), C2 (b), and C3 (c) displaying hydrogen bonding interactions.
Fig. 72D Fingerprint plots derived from the Hirshfeld surfaces displaying various intermolecular interactions.
Fig. 857Fe Mössbauer spectrum of C3 recorded at 298 K. The half width of the lines Γ/2 = 0.23(1) mm s−1.
Fig. 9XRPD pattern of the black powder issued from the synthesis of C3 compared to the computed XPRD pattern obtained from the cif file of C3.
Antibacterial activity of ligand and complexes (MIC, μg mL−1)
| Compound | MIC (μg mL−1) | |||
|---|---|---|---|---|
|
|
|
|
| |
| 3 | 10 | 10 | 20 | 5 |
| L1 | 20 | 20 | 20 | 20 |
| C1 | 5 | 5 | 5 | 10 |
| C2 | 5 | 10 | 5 | 20 |
| C3 | 20 | 5 | 10 | 20 |
| Chloramphenicol | 6.25 | 6.25 | 12.5 | 6.25 |
Antibacterial activity of C1, C2, C3 and other model complexes
| Metal complexes | Antibacterial activity (MIC in μg mL−1) | |||
|---|---|---|---|---|
|
|
|
| Ref. | |
| C1 | 5 | 5 | 5 | This work |
| C2 | 5 | 10 | 5 | This work |
| C3 | 20 | 5 | 10 | This work |
| [CuCl2(Fpy)2] | 310 | — | 150 |
|
| Cu(2,5-xil)2 | — | 31.2 | 31.2 |
|
| Cu(3,5-xil)2 | — | 31.2 | <15.6 |
|
| [Cu(Ligand)1(bipy)]ClO4·H2O | — | — | 125 |
|
| [Cu(Ligand)2(bipy)]ClO4·bipy | — | — | 62 |
|
| [Cu(Ligand)3(bipy)]ClO4·3H2O | — | — | 62 |
|
| [Cu(tL)2](BF4) | 256 | 256 | — |
|
| Cu(bcmpo) | 64 | 64 | 64 |
|
| Cu(bcmp) | 64 | 64 | 64 |
|
| [Fe(C18H14O2N10)Cl]Cl2 | 64 | 64 | 32 |
|
| [Fe(C18H14O2N10)(NO3)](NO3)2 | 128 | >128 | 64 |
|
| Cu(naph1pp)2 | 256 | 512 | 64 |
|
| Cu(naph2pp)2 | 256 | 256 | 256 |
|
| Cu(dansyl)2 | >512 | 512 | 512 |
|
| [Cu(HL1)(CH3CH2OH)](CH3COO) | 128 | 128 | 32 |
|
| [{CdCl(HATtsc)}2( | 25 | >100 | 25 |
|
| [{Cd(NO3)(HATtsc)}2( | 25 | >100 | 25 |
|
| [Cd3(bmesal)2(Cl)2] | 140 | — | — |
|
| [Cd(dbnu)] | 125 | — | 125 |
|
| [Cu(dbnu)] | 250 | — | 250 |
|
| [Cu(pdbpo)(NO3)(H2O)2] | 256 | 256 | 128 |
|
| [Cu(pdbpo)(SCN)(H2O)2] | 512 | 256 | 64 |
|
| [Cu(pdbpo)(ClO4)(H2O)2] | 512 | 256 | 128 |
|
| Cu(DL1) | >32 | — | >32 |
|
| Fe(LG) | >512 | >512 | 512 |
|
| Fe(Lp) | >512 | >512 | 256 |
|
Fpy = 2-fluoropyridine.
2,5-xil = 2,5-dimethylaniline, 3,5-xil = 3,5-dimethylaniline.
bipy = 2,2′-bipyridine; ligand = reaction between meso-1,2-diphenyl-1,2-ethylenediamine with salicylaldehyde (1), 5-bromosalicylaldehyde (2) or 3-methoxysalicylaldehyde (3).
tL = reaction of 2-aminofluorene with 2-pyridinecarboxaldehyde.
bcmpo = 3-bis(3′-carboxyl-5′-methyl-1′-pyrazolyl)propan-2-ol; bcmp = 1,3-bis(3′-carboxyl-5′-methyl-1′-pyrazolyl), 2-methyl propane.
naph1pp = 3-hydroxy-2-methyl-1-naphthyl-4-pyridinonate; naph2pp = 1-(N-naphthylcarbamoylpropyl)-3-hydroxy-2-methyl-4-pyridinonate; dansylpp = 2-(N-dansylaminomethyl)-3-hydroxy-1,6-dimethyl-4-pyridinonate.
HL1 = N,N′-bis(salicylidene)diethylenetriamine.
HATtsc = 2-acetyl-2-thiazoline thiosemicarbazone.
bmesal = N,N′-bis(3-methoxysalicylidenimino)-1,3-diaminopropane.
dbnu = 1,3-diethyl-1,3-bis(4-nitrophenyl)urea.
pdbpo = 1-phenyl-2,3-dimethyl-4-(N-2-hydroxy-4-methoxy-benzaldehyde)-3-pyrazolin-5-one.
DL1 = N,N′-bis(1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)ethylidene)malonohydrazide.
LG = 2-(((2-hydroxynaphthalen-1-yl)methylene)amino)e andthane-1,1-diol.
Lp = 2-(((2-hydroxynaphthalen-1-yl)methylene)amino)-2-phenylethane-1,1-diol.